Lung cancer becomes advanced when it spreads to the other lung or other parts of your body. Sometimes, it's called metastatic or stage IV disease. There are two main forms: non-small-cell lung ...

More information: Yuanning Zheng et al, Single-cell multimodal analysis reveals tumor microenvironment predictive of treatment response in non–small cell lung cancer, Science Advances (2025 ...

JNJ-1900 enhances radiation therapy effects while minimizing damage to healthy lung tissue, offering a promising approach for lung cancer treatment. Intratumoral therapies can reduce early treatment ...

As with all cancers, lung cancer has a preferred path when it spreads. Knowing where it tends to go can help you pick up on symptoms and let your health team know, so they can intervene early.

Lung cancer arises in tissues of the lung, usually in the cells lining air passages. The two main types are small-cell lung cancer and non-small-cell lung cancer, according to the shape of cells ...

Radiation therapy targets lung cancer at all stages, damaging tumor cell DNA to inhibit growth and division. Palliative radiation focuses on symptom relief in polymetastatic disease, using shorter, ...

Get Instant Summarized Text (Gist) Neoadjuvant immunotherapy with nivolumab plus chemotherapy before surgery in resectable non-small cell lung cancer increases five-year survival by about 10% ...

A new national lung cancer screening program starting in July is expected to detect an extra 1,500 cases each year. Lung cancer is the nation's deadliest cancer and advocates say the new screening ...

Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer.